39th ECNP Congress

The ECNP Congress, run by the European College of Neuropsychopharmacology, is Europe's leading scientific meeting on the science and treatment of brain disorders. The 39th edition takes place in Munich in a hybrid format: sessions are delivered in person at the ICM and almost all are livestreamed on the congress platform for virtual participants.

Who attends

Psychiatrists, neuroscientists, neurologists and psychologists from research, clinical practice and industry. The organizer reports 7,600+ attendees and 1,100+ poster presenters, with Early Career Scientists making up 45% of participants.

Programme

Four days combine scientific and industry content, following a published daily schedule.

• Keynote and plenary lectures
• Symposia and Educational Update Sessions
• Campfire Sessions and mini symposia
• Poster sessions, poster pitches and Top Paper Sessions
• Career development sessions for Early Career Scientists
• Love Your Brain sessions and a Lived Experience Session
• ECNP Neuropsychopharmacology Award Lecture and Excellence Award ceremonies
• Industry satellite symposia, product theatres and an exhibition

Keynote and plenary speakers

Kay Tye (USA) gives the keynote lecture, with plenary lectures from Julia Sacher and Frank Winkler (Germany), Ian Maze (USA), Lukoye Atwoli (Kenya), Lucia Valmaggia (Australia) and Oliver Howes (United Kingdom).

Tickets & passes

• Regular – member — EUR 825: Standard fee until 9 October; EUR 990 onsite. Excl. VAT
• Regular – non-member — EUR 1,045: Standard fee until 9 October; EUR 1,220 onsite. Excl. VAT
• CDE resident – member — EUR 455: Residents of a country with a developing economy; EUR 580 onsite
• Early Career Scientist – member — EUR 85: Aged 35 or under and resident in Europe; EUR 95 onsite
• Early Career Scientist – non-member — EUR 105: Aged 35 or under and resident in Europe; EUR 115 onsite